"4"^^ . . "Sedl\u00E1\u010Dkov\u00E1, Petra" . . . "Technology for the preparation of native, synthetic and recombinant antigens representing the main infectious agents threatening pregnancy"@en . . "\u0160teinbachov\u00E1, Marie" . "http://www.vidia.cz" . "The technology of the preparation of native antigens, synthetic antigens and peptides, their mixture selecting and its subsequent conjugation to the carrier protein, the procedure of preparation recombinant antigens comprising selecting a suitable expression system and the preparation of fusion proteins with a polyhistidine tag. Part of the description of the technology is to verify the functionality and suitability of antigens in the system immunoline."@en . . "- Proces ov\u011B\u0159en\u00ED je pops\u00E1n v protokolu o ov\u011B\u0159en\u00ED technologie \u010D. 002-2014. Popsan\u00E1 technologie je vhodn\u00E1 pro p\u0159\u00EDpravu antigen\u016F, jejich\u017E funk\u010Dnost a kvalita byly ov\u011B\u0159eny. Antigeny jsou funk\u010Dn\u00ED a diagnosticky vhodn\u00E9 pro detekci specifick\u00FDch protil\u00E1tek IgM/IgG proti antigen\u016Fm po\u017Eadovan\u00FDch infek\u010Dn\u00EDch agens. Vyvinut\u00E9 technologie p\u0159\u00EDpravy nativn\u00EDch, rekombinantn\u00EDch a syntetick\u00FDch peptidov\u00FDch antigen\u016F jsou vhodn\u00E9 pro dan\u00E9 pou\u017Eit\u00ED. Technologie bude d\u00E1le vyu\u017Eita ve spole\u010Dnosti VIDIA, Nad Safinou II 365, 25242 Jesenice pro p\u0159\u00EDpravu multiplexov\u00E9ho testu pro diagnostiku infekc\u00ED v t\u011Bhotenstv\u00ED. Odpov\u011Bdn\u00E1 osoba M. \u0160teinbachov\u00E1, tel. 261090568, e-mail: steinbachova@vidia.cz" . "Ov\u011B\u0159en\u00E1 technologie pro p\u0159\u00EDpravu nativn\u00EDch, syntetick\u00FDch a rekombinantn\u00EDch antigen\u016F reprezentuj\u00EDc\u00ED hlavn\u00ED p\u016Fvodce infekc\u00ED ohro\u017Euj\u00EDc\u00EDch t\u011Bhotenstv\u00ED" . "6"^^ . . "Ov\u011B\u0159en\u00E1 technologie pro p\u0159\u00EDpravu nativn\u00EDch, syntetick\u00FDch a rekombinantn\u00EDch antigen\u016F reprezentuj\u00EDc\u00ED hlavn\u00ED p\u016Fvodce infekc\u00ED ohro\u017Euj\u00EDc\u00EDch t\u011Bhotenstv\u00ED" . "Technology for the preparation of native, synthetic and recombinant antigens representing the main infectious agents threatening pregnancy"@en . "Roubalov\u00E1, Kate\u0159ina" . "35410" . "Postup p\u0159\u00EDpravy nativn\u00EDch antigen\u016F, rekombinantn\u00EDch antigen\u016F a peptid\u016F, v\u00FDb\u011Br vhodn\u00E9 sm\u011Bsi a jejich n\u00E1sledn\u00E1 konjugace s nosi\u010Dov\u00FDm proteinem, d\u00E1le postup p\u0159\u00EDpravy rekombinantn\u00EDch antigen\u016F zahrnuj\u00EDc\u00ED v\u00FDb\u011Br vhodn\u00E9ho expresn\u00EDho syst\u00E9mu a p\u0159\u00EDpravu f\u00FAzn\u00EDch protein\u016F s polyhistidinovou kotvou. Sou\u010D\u00E1st\u00ED popisu technologie je ov\u011B\u0159en\u00ED funk\u010Dnosti a vhodnosti antigen\u016F v syst\u00E9mu immunoline."@cs . . . "Ov\u011B\u0159en\u00E1 technologie pro p\u0159\u00EDpravu nativn\u00EDch, syntetick\u00FDch a rekombinantn\u00EDch antigen\u016F reprezentuj\u00EDc\u00ED hlavn\u00ED p\u016Fvodce infekc\u00ED ohro\u017Euj\u00EDc\u00EDch t\u011Bhotenstv\u00ED"@cs . . . "Ov\u011B\u0159en\u00E1 technologie pro p\u0159\u00EDpravu nativn\u00EDch, syntetick\u00FDch a rekombinantn\u00EDch antigen\u016F reprezentuj\u00EDc\u00ED hlavn\u00ED p\u016Fvodce infekc\u00ED ohro\u017Euj\u00EDc\u00EDch t\u011Bhotenstv\u00ED"@cs . "infection; pregnancy; imunoline; LIA"@en . . . . "RIV/16556267:_____/14:#0000154" . "Franko, Filip" . "Postup p\u0159\u00EDpravy nativn\u00EDch antigen\u016F, rekombinantn\u00EDch antigen\u016F a peptid\u016F, v\u00FDb\u011Br vhodn\u00E9 sm\u011Bsi a jejich n\u00E1sledn\u00E1 konjugace s nosi\u010Dov\u00FDm proteinem, d\u00E1le postup p\u0159\u00EDpravy rekombinantn\u00EDch antigen\u016F zahrnuj\u00EDc\u00ED v\u00FDb\u011Br vhodn\u00E9ho expresn\u00EDho syst\u00E9mu a p\u0159\u00EDpravu f\u00FAzn\u00EDch protein\u016F s polyhistidinovou kotvou. Sou\u010D\u00E1st\u00ED popisu technologie je ov\u011B\u0159en\u00ED funk\u010Dnosti a vhodnosti antigen\u016F v syst\u00E9mu immunoline." . "And\u011Bra, Ladislav" . . . . . "[596A9F17DF4E]" . "RIV/16556267:_____/14:#0000154!RIV15-TA0-16556267" . "zaveden\u00ED nov\u00E9ho typu v\u00FDroby, z\u00EDsk\u00E1n\u00ED nov\u00FDch z\u00E1kazn\u00EDk\u016F" . . . . . "P(TA03010625)" . . "Lep\u0161a, Lud\u011Bk" . "OT 002-2014" . .